Development and comparison between three type of checkpoint inhibitor drug

Abstract

In the recent years, many monoclonal antibody drugs related to the immunotherapy is taken by many cancer patients. This passage will give the information about the three common checkpoint inhibitor drugs. Information of each of drug will be divide into three parts including mechanism and structure, efficiency and strength, drawback and side-effect. Then limitation and new improvement of checkpoint inhibitor drugs of all three drugs will be introduced in the last part.